{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:31:39Z","timestamp":1792445499062,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Tumor-associated nerves have recently emerged as an understudied key regulator of cancer biology. However, its quantification using histological or transcriptomic approaches is challenging because their small diameters hinder reliable detection and their cell bodies that hold most mRNA reside outside the tumor. This study evaluated a Schwann cell (SC)-related transcriptomic score as a surrogate for tumor-associated nerves in tumors from triple-negative breast cancer (TNBC) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Transcriptomic and clinical data from three independent TNBC cohorts, TCGA (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009170), METABRIC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009335), and SCAN-B (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009174) were analyzed. An SC score was calculated from SC-related gene signatures, and spatial transcriptomics was used to validate SC localization. In addition, seven independent neoadjuvant chemotherapy (NAC) cohorts were analyzed to evaluate the association between SC score and treatment response. Associations between the SC score and clinical features, genomic features, proliferation, treatment response, and the tumor microenvironment (TME) were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SC signature genes spatially localized to intratumoral nerve regions, confirming that the SC score reflects their presence within tumors. SC-high tumors were associated with lower mutation burden and with less cell proliferation in the TCGA, METABRIC, and SCAN-B cohorts. SC-high tumors were also associated with low immune activity and fewer infiltrating immune cells, along with enrichment of epithelial\u2013mesenchymal transition (EMT), TGF-beta signaling and stromal remodeling pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The SC score-high TNBC is associated with lower cell proliferation, enhanced stromal remodeling and EMT and suppressed immune activity, suggesting a role of neural-associated TME features in shaping TNBC biology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-026-08050-z","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:16:56Z","timestamp":1786349816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of tumor Schwann cells with epithelial-mesenchymal transition and immune-suppressive microenvironment in triple-negative breast cancer"],"prefix":"10.1007","volume":"218","author":[{"given":"Kei","family":"Kawashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eslam A.","family":"Elsaedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Oshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimitsu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Narui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipara","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Repasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Takabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"8","key":"8050_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41568-025-00831-w","volume":"25","author":"M Amit","year":"2025","unstructured":"Amit M, Eichwald T, Roger A, Anderson J, Chang A, Vermeer PD et al (2025) Neuro-immune cross-talk in cancer. Nat Rev Cancer 25(8):573\u2013 589","journal-title":"Nat Rev Cancer"},{"key":"8050_CR2","doi-asserted-by":"publisher","first-page":"104871","DOI":"10.1016\/j.critrevonc.2025.104871","volume":"213","author":"X Wang","year":"2025","unstructured":"Wang X, Pan Y, Zhou Y, Tang T, Li F, Li H (2025) The peripheral tumor neuro-microenvironment: Deciphering neural landscape and mechanistic insights for therapeutic innovation. Crit Rev Oncol Hematol 213:104871","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"8050_CR3","doi-asserted-by":"publisher","first-page":"e2200187","DOI":"10.1002\/adbi.202200187","volume":"6","author":"MD Santi","year":"2022","unstructured":"Santi MD, Zhang M, Salvo E, Asam K, Viet CT, Xie T et al (2022) Schwann Cells Induce Phenotypic Changes in Oral Cancer Cells. Adv Biol (Weinh) 6(9):e2200187","journal-title":"Adv Biol (Weinh)"},{"issue":"9","key":"8050_CR4","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-14-3180","volume":"75","author":"P Jobling","year":"2015","unstructured":"Jobling P, Pundavela J, Oliveira SM, Roselli S, Walker MM, Hondermarck H (2015) Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression. Cancer Res 75(9):1777\u20131781","journal-title":"Cancer Res"},{"key":"8050_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/cancers14215246","volume":"14","author":"M Gola","year":"2022","unstructured":"Gola M, Sejda A, Godlewski J, Cieslak M, Starzynska A (2022) Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma. Cancers (Basel) 14:21","journal-title":"Cancers (Basel)"},{"issue":"1","key":"8050_CR6","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1038\/s41598-021-86831-w","volume":"11","author":"A Ferdoushi","year":"2021","unstructured":"Ferdoushi A, Griffin N, Marsland M, Xu X, Faulkner S, Gao F et al (2021) Tumor innervation and clinical outcome in pancreatic cancer. Sci Rep 11(1):7390","journal-title":"Sci Rep"},{"issue":"23","key":"8050_CR7","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-08-1164","volume":"14","author":"GE Ayala","year":"2008","unstructured":"Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM et al (2008) Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin Cancer Res 14(23):7593\u20137603","journal-title":"Clin Cancer Res"},{"issue":"6142","key":"8050_CR8","doi-asserted-by":"publisher","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ et al (2013) Autonomic nerve development contributes to prostate cancer progression. Science 341(6142):1236361","journal-title":"Science"},{"issue":"7795","key":"8050_CR9","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41586-020-1996-3","volume":"578","author":"M Amit","year":"2020","unstructured":"Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR et al (2020) Loss of p53 drives neuron reprogramming in head and neck cancer. Nature 578(7795):449\u2013454","journal-title":"Nature"},{"issue":"13","key":"8050_CR10","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1158\/1078-0432.CCR-22-3496","volume":"29","author":"C Perez-Pacheco","year":"2023","unstructured":"Perez-Pacheco C, Schmitd LB, Furgal A, Bellile EL, Liu M, Fattah A et al (2023) Increased Nerve Density Adversely Affects Outcome in Oral Cancer. Clin Cancer Res 29(13):2501\u20132512","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8050_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12967-025-06104-2","volume":"23","author":"H Wang","year":"2025","unstructured":"Wang H, Huo R, He K, Li W, Gao Y, He W et al (2025) Increased nerve density adversely affects outcome in colorectal cancer and denervation suppresses tumor growth. J Transl Med 23(1):112","journal-title":"J Transl Med"},{"issue":"21","key":"8050_CR12","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1002\/cncr.26117","volume":"117","author":"D Albo","year":"2011","unstructured":"Albo D, Akay CL, Marshall CL, Wilks JA, Verstovsek G, Liu H et al (2011) Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer 117(21):4834\u20134845","journal-title":"Cancer"},{"key":"8050_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/1471-2407-14-484","volume":"14","author":"Q Zhao","year":"2014","unstructured":"Zhao Q, Yang Y, Liang X, Du G, Liu L, Lu L et al (2014) The clinicopathological significance of neurogenesis in breast cancer. BMC Cancer 14:484","journal-title":"BMC Cancer"},{"issue":"6","key":"8050_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1096\/fba.2021-00147","volume":"4","author":"D Li","year":"2022","unstructured":"Li D, Hu LN, Zheng SM, La T, Wei LY, Zhang XJ et al (2022) High nerve density in breast cancer is associated with poor patient outcome. FASEB Bioadv 4(6):391\u2013401","journal-title":"FASEB Bioadv"},{"key":"8050_CR15","doi-asserted-by":"crossref","unstructured":"Kawashima K, Chida K, Oshi M, Yamada A, Narui K, Gandhi S, Ebos MLJ, Abrams IS, Bhattacharjee A, Endo I, Takabe K (2026) A neuron projection guidance signature associates with immune-cold tumor microenvironment and poor outcomes in breast cancer. Ann Surg Oncol (In press)","DOI":"10.1245\/s10434-026-19932-3"},{"issue":"6","key":"8050_CR16","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1158\/2159-8290.CD-18-1398","volume":"9","author":"S Faulkner","year":"2019","unstructured":"Faulkner S, Jobling P, March B, Jiang CC, Hondermarck H (2019) Tumor Neurobiology and the War of Nerves in Cancer. Cancer Discov 9(6):702\u2013710","journal-title":"Cancer Discov"},{"key":"8050_CR17","doi-asserted-by":"crossref","unstructured":"Ali SR, Jordan M, Nagarajan P, Amit M (2022) Nerve density and neuronal biomarkers in cancer. Cancers (Basel) 14(19):4817","DOI":"10.3390\/cancers14194817"},{"issue":"2","key":"8050_CR18","doi-asserted-by":"publisher","first-page":"e1009912","DOI":"10.1371\/journal.pcbi.1009912","volume":"18","author":"IP Astono","year":"2022","unstructured":"Astono IP, Welsh JS, Rowe CW, Jobling P (2022) Objective quantification of nerves in immunohistochemistry specimens of thyroid cancer utilising deep learning. PLoS Comput Biol 18(2):e1009912","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"8050_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41523-022-00485-z","volume":"8","author":"TT Le","year":"2022","unstructured":"Le TT, Payne SL, Buckwald MN, Hayes LA, Parker SR, Burge CB et al (2022) Sensory nerves enhance triple-negative breast cancer invasion and metastasis via the axon guidance molecule PlexinB3. NPJ Breast Cancer 8(1):116","journal-title":"NPJ Breast Cancer"},{"issue":"7935","key":"8050_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-022-05374-w","volume":"611","author":"M Balood","year":"2022","unstructured":"Balood M, Ahmadi M, Eichwald T, Ahmadi A, Majdoubi A, Roversi K et al (2022) Nociceptor neurons affect cancer immunosurveillance. Nature 611(7935):405\u2013412","journal-title":"Nature"},{"key":"8050_CR21","doi-asserted-by":"publisher","first-page":"1335387","DOI":"10.3389\/fimmu.2024.1335387","volume":"15","author":"U Mardelle","year":"2024","unstructured":"Mardelle U, Bretaud N, Daher C, Feuillet V (2024) From pain to tumor immunity: influence of peripheral sensory neurons in cancer. Front Immunol 15:1335387","journal-title":"Front Immunol"},{"issue":"3","key":"8050_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka AH, Frenette PS (2020) Nerves in cancer. Nat Rev Cancer 20(3):143\u2013157","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"8050_CR23","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41583-020-00407-7","volume":"22","author":"I Dalla Costa","year":"2021","unstructured":"Dalla Costa I, Buchanan CN, Zdradzinski MD, Sahoo PK, Smith TP, Thames E et al (2021) The functional organization of axonal mRNA transport and translation. Nat Rev Neurosci 22(2):77\u201391","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"8050_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.mcn.2009.06.002","volume":"42","author":"CF Vogelaar","year":"2009","unstructured":"Vogelaar CF, Gervasi NM, Gumy LF, Story DJ, Raha-Chowdhury R, Leung KM et al (2009) Axonal mRNAs: characterisation and role in the growth and regeneration of dorsal root ganglion axons and growth cones. Mol Cell Neurosci 42(2):102\u2013115","journal-title":"Mol Cell Neurosci"},{"issue":"8060","key":"8050_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-025-08735-3","volume":"640","author":"V Thiel","year":"2025","unstructured":"Thiel V, Renders S, Panten J, Dross N, Bauer K, Azorin D et al (2025) Characterization of single neurons reprogrammed by pancreatic cancer. Nature 640(8060):1042\u20131051","journal-title":"Nature"},{"key":"8050_CR26","doi-asserted-by":"crossref","unstructured":"Campana WM, Armati PJ, Mathey EK (2007) Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav ImmunJ Neurol Sci 21(5):522\u2013527","DOI":"10.1016\/j.bbi.2006.12.008"},{"key":"8050_CR27","doi-asserted-by":"crossref","unstructured":"Khorani K, Burkart S, Weusthof C, Han R, Liang S, Stogbauer F et al (2024) Context-dependent regulation of peripheral nerve abundance by the PI3K Pathway in the tumor microenvironment of head and neck squamous cell carcinoma. Cells 13(12):1033","DOI":"10.3390\/cells13121033"},{"issue":"27","key":"8050_CR28","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.1097\/MD.0000000000000172","volume":"93","author":"D Huang","year":"2014","unstructured":"Huang D, Su S, Cui X, Shen X, Zeng Y, Wu W et al (2014) Nerve fibers in breast cancer tissues indicate aggressive tumor progression. Med (Baltim) 93(27):e172","journal-title":"Med (Baltim)"},{"key":"8050_CR29","doi-asserted-by":"crossref","unstructured":"Bloomer H, Parker SR, Pierce AL, Clawson W, Caron MM, Gerton T et al (2025) Triple-negative breast cancer cells activate sensory neurons via TRPV1 to Drive nerve outgrowth and tumor progression. bioRxiv","DOI":"10.1101\/2025.07.22.666151"},{"issue":"4","key":"8050_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cell.2026.01.001","volume":"189","author":"SW Zhang","year":"2026","unstructured":"Zhang SW, Wang H, Xiao Y, Liu LT, Shen M, Wang Z et al (2026) Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment. Cell 189(4):1039\u201355e20","journal-title":"Cell"},{"issue":"8075","key":"8050_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41586-025-09176-8","volume":"644","author":"G Hoover","year":"2025","unstructured":"Hoover G, Gilbert S, Curley O, Obellianne C, Lin MT, Hixson W et al (2025) Nerve-to-cancer transfer of mitochondria during cancer metastasis. Nature 644(8075):252\u2013262","journal-title":"Nature"},{"issue":"44","key":"8050_CR32","doi-asserted-by":"publisher","first-page":"76606","DOI":"10.18632\/oncotarget.20609","volume":"8","author":"M Austin","year":"2017","unstructured":"Austin M, Elliott L, Nicolaou N, Grabowska A, Hulse RP (2017) Breast cancer induced nociceptor aberrant growth and collateral sensory axonal branching. Oncotarget 8(44):76606\u201376621","journal-title":"Oncotarget"},{"issue":"8028","key":"8050_CR33","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-024-07767-5","volume":"633","author":"V Padmanaban","year":"2024","unstructured":"Padmanaban V, Keller I, Seltzer ES, Ostendorf BN, Kerner Z, Tavazoie SF (2024) Neuronal substance P drives metastasis through an extracellular RNA-TLR7 axis. Nature 633(8028):207\u2013215","journal-title":"Nature"},{"key":"8050_CR34","doi-asserted-by":"publisher","first-page":"217748","DOI":"10.1016\/j.canlet.2025.217748","volume":"624","author":"L Huang","year":"2025","unstructured":"Huang L, Qi G, Chen G, Duan J, Dai C, Lu Y et al (2025) Tumor-associated Schwann cells as new therapeutic target in non-neurological cancers. Cancer Lett 624:217748","journal-title":"Cancer Lett"},{"issue":"9","key":"8050_CR35","doi-asserted-by":"publisher","first-page":"e2200089","DOI":"10.1002\/adbi.202200089","volume":"6","author":"S Deborde","year":"2022","unstructured":"Deborde S, Wong RJ (2022) The Role of Schwann Cells in Cancer. Adv Biol (Weinh) 6(9):e2200089","journal-title":"Adv Biol (Weinh)"},{"issue":"13","key":"8050_CR36","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1113\/JP270874","volume":"594","author":"KR Jessen","year":"2016","unstructured":"Jessen KR, Mirsky R (2016) The repair Schwann cell and its function in regenerating nerves. J Physiol 594(13):3521\u20133531","journal-title":"J Physiol"},{"issue":"11","key":"8050_CR37","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/glia.23643","volume":"67","author":"S Stierli","year":"2019","unstructured":"Stierli S, Imperatore V, Lloyd AC (2019) Schwann cell plasticity-roles in tissue homeostasis, regeneration, and disease. Glia 67(11):2203\u20132215","journal-title":"Glia"},{"key":"8050_CR38","doi-asserted-by":"publisher","first-page":"1506552","DOI":"10.3389\/fphar.2025.1506552","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Xie J, Dai W, Lu B, Yi S (2025) Schwann cells in regeneration and cancer. Front Pharmacol 16:1506552","journal-title":"Front Pharmacol"},{"issue":"3","key":"8050_CR39","doi-asserted-by":"publisher","first-page":"240337","DOI":"10.1098\/rsob.240337","volume":"15","author":"F Gracia","year":"2025","unstructured":"Gracia F, Sanchez-Laorden B, Gomez-Sanchez JA (2025) Schwann cells in regeneration and cancer: an epithelial-mesenchymal transition perspective. Open Biol 15(3):240337","journal-title":"Open Biol"},{"issue":"1","key":"8050_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1096\/fba.2021-00066","volume":"4","author":"AC Restaino","year":"2022","unstructured":"Restaino AC, Vermeer PD (2022) Neural regulations of the tumor microenvironment. FASEB Bioadv 4(1):29\u201342","journal-title":"FASEB Bioadv"},{"issue":"3","key":"8050_CR41","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41(3):374\u2013403","journal-title":"Cancer Cell"},{"issue":"1","key":"8050_CR42","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Venet D, Lifrange F, Larsimont D, Rediti M, Stenbeck L et al (2024) Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat Commun 15(1):10232","journal-title":"Nat Commun"},{"issue":"6","key":"8050_CR43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","volume":"40","author":"DM Wolf","year":"2022","unstructured":"Wolf DM, Yau C, Wulfkuhle J, Brown-Swigart L, Gallagher RI, Lee PRE et al (2022) Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies. Cancer Cell 40(6):609\u2013623 e6","journal-title":"Cancer Cell"},{"issue":"18","key":"8050_CR44","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A et al (2011) A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305(18):1873\u20131881","journal-title":"JAMA"},{"key":"8050_CR45","doi-asserted-by":"publisher","first-page":"948601","DOI":"10.3389\/fimmu.2022.948601","volume":"13","author":"J Chen","year":"2022","unstructured":"Chen J, Hao L, Qian X, Lin L, Pan Y, Han X (2022) Machine learning models based on immunological genes to predict the response to neoadjuvant therapy in breast cancer patients. Front Immunol 13:948601","journal-title":"Front Immunol"},{"issue":"1","key":"8050_CR46","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1038\/s41467-020-19933-0","volume":"11","author":"YH Park","year":"2020","unstructured":"Park YH, Lal S, Lee JE, Choi YL, Wen J, Ram S et al (2020) Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome. Nat Commun 11(1):6175","journal-title":"Nat Commun"},{"issue":"21","key":"8050_CR47","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1158\/1078-0432.CCR-10-1265","volume":"16","author":"A Tabchy","year":"2010","unstructured":"Tabchy A, Valero V, Vidaurre T, Lluch A, Gomez H, Martin M et al (2010) Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer. Clin Cancer Res 16(21):5351\u20135361","journal-title":"Clin Cancer Res"},{"issue":"3","key":"8050_CR48","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s12282-025-01687-6","volume":"32","author":"Y Sota","year":"2025","unstructured":"Sota Y, Seno S, Naoi Y, Honma K, Shimoda M, Tanei T et al (2025) IRSN-23 gene diagnosis enhances breast cancer subtype classification and predicts response to neoadjuvant chemotherapy: new validation analyses. Breast Cancer 32(3):566\u2013581","journal-title":"Breast Cancer"},{"issue":"6","key":"8050_CR49","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1158\/1078-0432.CCR-12-1359","volume":"19","author":"CE Horak","year":"2013","unstructured":"Horak CE, Pusztai L, Xing G, Trifan OC, Saura C, Tseng LM et al (2013) Biomarker analysis of neoadjuvant doxorubicin\/cyclophosphamide followed by ixabepilone or Paclitaxel in early-stage breast cancer. Clin Cancer Res 19(6):1587\u20131595","journal-title":"Clin Cancer Res"},{"key":"8050_CR50","doi-asserted-by":"crossref","unstructured":"Franzen O, Gan LM, Bjorkegren JLM (2019) PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data. Database (Oxford). ;2019","DOI":"10.1093\/database\/baz046"},{"issue":"1","key":"8050_CR51","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ (2017) xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol 18(1):220","journal-title":"Genome Biol"},{"issue":"1\u20132","key":"8050_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N (2015) Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160(1\u20132):48\u201361","journal-title":"Cell"},{"issue":"4","key":"8050_CR53","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH et al (2018) The Immune Landscape of Cancer. Immunity 48(4):812\u2013830 e14","journal-title":"Immunity"},{"issue":"6","key":"8050_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P (2015) The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 1(6):417\u2013425","journal-title":"Cell Syst"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08050-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08050-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08050-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:48:56Z","timestamp":1787640536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08050-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["8050"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08050-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declaration"}}],"article-number":"37"}}